
NVDA
- Market cap
- $3.17T
- Sector
- Information technology

Based on 35 analysts for FY2027
Dollars per share. The record, then the analysts' mean; the dashed lines are their lowest and highest estimate; Oryn's base case is the accent line.
Illustrative estimates; Oryn's line is the base case its DCF run of 8 Sep 2026 stored
Solid, filled: reported, then the consensus meanDashed: the lowest and highest estimateAccent: Oryn's base case, as its DCF run stored it
Oryn's base case against the consensus mean, earnings per share
Each year on one scale, as a difference from that year's consensus mean (the ink line, 0%). The accent mark is Oryn's base case; the grey band is its bear-to-bull range.
Illustrative estimates and paths
Oryn's bear, base and bull are the cases its DCF run of 8 Sep 2026 stored (run run-nvda), year by year. A "Consensus" year is one the run took from the analysts' panel; a "Fade" year is the run's own past it.
Oryn's EPS is each case's net income over the run's 24.60B shares outstanding, counted on 8 Sep 2026; the analysts' EPS is diluted, so at equal earnings Oryn's reads a little higher.
Where this page's consensus covers the year, Oryn's base case is up to +5.6% from its mean: the run read the consensus as of its own date and divides by its own share count.
FY2030–FY2031: the run's fade past the analysts' panel, growth narrowing toward its terminal rate with the margin held.
| Fiscal year | Reported | Consensus low | Consensus mean | Consensus high | Analysts | Oryn bear | Oryn base | Oryn bull | Base vs consensus | Oryn year from |
|---|---|---|---|---|---|---|---|---|---|---|
| FY2022 | $0.31 | — | — | — | — | — | — | — | — | — |
| FY2023 | $0.36 | — | — | — | — | — | — | — | — | — |
| FY2024 | $0.92 | — | — | — | — | — | — | — | — | — |
| FY2025 | $2.25 | — | — | — | — | — | — | — | — | — |
| FY2026 | $4.04 | — | — | — | — | — | — | — | — | — |
| FY2027 | — | $5.70 | $6.07 | $6.56 | 35 | $5.76 | $6.13 | $6.63 | +1.0% | Consensus |
| FY2028 | — | $6.91 | $7.80 | $8.83 | 29 | $6.98 | $8.14 | $8.92 | +4.4% | Consensus |
| FY2029 | — | $8.52 | $9.98 | $11.81 | 23 | $8.61 | $10.54 | $11.93 | +5.6% | Consensus |
| FY2030 | — | — | — | — | — | $9.59 | $12.00 | $13.77 | — | Fade |
| FY2031 | — | — | — | — | — | $9.88 | $12.36 | $14.18 | — | Fade |
Q3 FY2027, from 36 analysts
Moved in ninety days
4 quarters and 3 fiscal years
| Period | Revenue | Earnings per share | Analysts | Revision, 90 days |
|---|---|---|---|---|
| Quarters | ||||
| Q3 FY2027 | $73.49B | $1.70 | 36 | +1.1% |
| Q4 FY2027 | $77.90B | $1.80 | 34 | +0.5% |
| Q1 FY2028 | $78.92B | $1.86 | 32 | −0.1% |
| Q2 FY2028 | $81.40B | $1.92 | 30 | −0.2% |
| Fiscal years | ||||
| FY2027 | $267.01B | $6.07 | 35 | +2.3% |
| FY2028 | $330.56B | $7.80 | 29 | −0.7% |
| FY2029 | $408.57B | $9.98 | 23 | −0.6% |
| Period | Revenue | Estimate | Surprise | Earnings per share | Estimate | Surprise | Analysts |
|---|---|---|---|---|---|---|---|
| Quarters | |||||||
| Q2 FY2027 | $58.70B | $58.10B | +1.0% | $1.30 | $1.31 | −0.8% | 30 |
| Q1 FY2027 | $56.92B | $57.67B | −1.3% | $1.27 | $1.26 | +0.8% | 36 |
| Q4 FY2026 | $63.18B | $62.27B | +1.5% | $1.40 | $1.34 | +4.5% | 31 |
| Q3 FY2026 | $59.60B | $58.73B | +1.5% | $1.33 | $1.27 | +4.7% | 33 |
| Fiscal years | |||||||
| FY2026 | $205.60B | $207.04B | −0.7% | $4.04 | $3.86 | +4.7% | 32 |
| FY2025 | $130.50B | $129.07B | +1.1% | $2.25 | $2.28 | −1.3% | 33 |
Target range vs price
The grey band spans the lowest and highest published target; the marked figure is the mean of 39 targets and the vertical line is today’s price.
Published targets collected to 8 Sep 2026 · third-party; not an Oryn output